BIOCON.BOBIOCON.BOBSE
Loading
Year-over-year SG&A expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P26
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
3.06%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -100.00% |
| Q2 2025 | -28.46% |
| Q1 2025 | 47.72% |
| Q4 2024 | -0.16% |
| Q3 2024 | 4.53% |
| Q2 2024 | -18.77% |
| Q1 2024 | 29.02% |
| Q4 2023 | 15.81% |
| Q3 2023 | 7.44% |
| Q2 2023 | -19.70% |
| Q1 2023 | 29.10% |
| Q4 2022 | 3.42% |
| Q3 2022 | 5.40% |
| Q2 2022 | -20.42% |
| Q1 2022 | 30.12% |
| Q4 2021 | 3.38% |
| Q3 2021 | 9.82% |
| Q2 2021 | -5.13% |
| Q1 2021 | -0.80% |
| Q4 2020 | 7.27% |
| Q3 2020 | 9.70% |
| Q2 2020 | -32.60% |
| Q1 2020 | 55.30% |
| Q4 2019 | 6.45% |
| Q3 2019 | 3.61% |
| Q2 2019 | 6.36% |
| Q1 2019 | 8.90% |
| Q4 2018 | 1.90% |
| Q3 2018 | 10.52% |
| Q2 2018 | 1.71% |
| Q1 2018 | 9.22% |
| Q4 2017 | 4.35% |
| Q3 2017 | 5.72% |
| Q2 2017 | 7.78% |
| Q1 2017 | 1.91% |
| Q4 2016 | 7.65% |
| Q3 2016 | 1.06% |
| Q2 2016 | 19.00% |
| Q1 2016 | -5.60% |